ARTICLE | Clinical News
Alicaforsen: Phase III started
February 15, 2016 8:00 AM UTC
Atlantic began a double-blind, placebo-controlled, international Phase III trial to evaluate 240 mg topical alicaforsen enema once daily for 6 weeks in 138 patients with active, chronic, antibiotic-re...